LEVI vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LEVI presents a compelling growth-at-a-reasonable-price (GARP) opportunity, anchored by a stable Piotroski F-Score of 4/9 and a current price ($22.30) that sits comfortably below its growth-based intrinsic value of $40.12. While the Graham Number suggests a lower defensive floor of $13.25, the company's exceptional ROE of 25.41% and strong earnings growth (32.6% YoY) justify a premium. Despite bearish insider sentiment and a weak technical trend, the fundamental trajectory is supported by consistent earnings beats and a P/E ratio significantly lower than the sector average.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
LEVI vs TSLA: Head-to-Head Comparison
This page compares Levi Strauss & Co. (LEVI) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.